8-OH-DPAT (hydrobromide)
8-OH-DPAT (8-Hydroxy-DPAT) hydrobromide is a potent and selective 5-HT1A agonist with a pIC50 of 8.19. 8-OH-DPAT hydrobromide has selectivity of almost 1000 fold for a subtype of the 5-HT1 binding site[1].
Product Specifications
CAS Number
[76135-31-4]
Product Name Alternative
8-Hydroxy-DPAT (hydrobromide)
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
5-HT Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/8-oh-dpat-hydrobromide.html
Concentration
10mM
Purity
99.88
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
OC1=C2CC(N(CCC)CCC)CCC2=CC=C1.[H]Br
Molecular Formula
C16H26BrNO
Molecular Weight
328.29
Precautions
H315, H319, H335
References & Citations
1
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
5-HT1 Receptor; mLAG-3
Citation 01
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ARE Activator, BTZO-1 (Macrophage Migration Inhibitory Factor Antagonist II, 2-Pyridin-2-yl-4H-1,3-benzothiazin-4-one, MIF Antagonist II) discontinued